News
Should ALPS Equal Sector Weight ETF (EQL) Be on Your Investing Radar?
Launched on July 7, 2009, the ALPS Equal Sector Weight ETF (EQL) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity
Is iShares Emerging Markets Dividend ETF (DVYE) a Strong ETF Right Now?
The iShares Emerging Markets Dividend ETF (DVYE) was launched on 02/23/2012, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Emerging Market ETFs category of
Is First Trust RBA American Industrial Renaissance ETF (AIRR) a Strong ETF Right Now?
Designed to provide broad exposure to the Industrials ETFs category of the market, the First Trust RBA American Industrial Renaissance ETF (AIRR) is a smart beta exchange traded fund launched on
Should Pacer US Small Cap Cash Cows ETF (CALF) Be on Your Investing Radar?
Launched on June 16, 2017, the Pacer US Small Cap Cash Cows ETF (CALF) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Value segment of the US
Ionis Pharmaceuticals Touts $3B TRYNGOLZA Opportunity, Pipeline Readouts at Conference
Key Points
- Interested in Ionis Pharmaceuticals, Inc.? Here are five stocks we like better.
- Ionis Pharmaceuticals said TRYNGOLZA could become a more than $3 billion U.S. product in severe
New Strong Buy Stocks for May 18th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Ovintiv Inc. OVV: This oil and gas exploration and production company has seen the Zacks Consensus Estimate for its current
New Strong Sell Stocks for May 18th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Adecco Group AG AHEXY is a human resources company. The Zacks Consensus Estimate for its current year earnings has been
Best Growth Stocks to Buy for May 18th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, May 18:
Valero Energy Corporation VLO: This energy company carries a Zacks Rank #1, and has
Best Value Stocks to Buy for May 18th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 18:
Kohl's Corporation KSS: This retail company carries a Zacks Rank #1, and has witnessed
Best Income Stocks to Buy for May 18th
Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 18:
Mach Natural Resources LP MNR: This oil and gas company witnessed the Zacks Consensus
SMA Solar Technology Q1 Earnings Call Highlights
Key Points
- Interested in SMA Solar Technology AG? Here are five stocks we like better.
- SMA Solar posted modest Q1 2026 growth, with sales up 4% to EUR 341 million and operating EBITDA rising
Bull of the Day: Progyny (PGNY)
Healthcare innovators don’t always come with flashy headlines, but the companies quietly reshaping how employers manage care costs can become some of the market’s strongest long-term winners. That’s
Bear of the Day: Standex International (SXI)
Standex International Corporation SXI) has long been viewed as a viable industrial products manufacturer with exposure to electronics, engineering technologies, and specialty manufacturing markets.
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus
Key Points
- Interested in Insmed, Inc.? Here are five stocks we like better.
- Insmed defended the BRINSUPRI launch after investors worried about discontinuation rates, saying the drug’s $208
Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build
Key Points
- Interested in Incyte Corporation? Here are five stocks we like better.
- Incyte’s CEO says the company’s post-Jakafi growth path is becoming clearer as its commercial business
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data
Key Points
- Interested in IDEAYA Biosciences, Inc.? Here are five stocks we like better.
- IDEAYA Biosciences said its lead melanoma drug, darovasertib, is on track for an NDA submission after
InterDigital Maps Path to $1B Recurring Revenue on Patents, Streaming Push
Key Points
- Interested in InterDigital, Inc.? Here are five stocks we like better.
- InterDigital said it is on track toward a long-term goal of more than $1 billion in annualized recurring
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while
Horizon Quantum Computing Pte. Lays Out Quantum Software Push at Needham Conference
Horizon Quantum Computing Pte. (NASDAQ:HQ) used its appearance at Needham & Company’s 21st annual Technology, Media, & Consumer
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related
Green Plains Touts Operational Gains, Carbon Capture Upside at Conference
Green Plains (NASDAQ:GPRE) executives said the company’s recent performance has been driven by tighter operating discipline, a simplified business structure and new
Alphabet’s YouTube CEO Touts AI, Creators and TV as Growth Flywheel
YouTube CEO Neal Mohan said the Alphabet (NASDAQ:GOOG) video platform is continuing to lean on creators, subscriptions, connected TV and
Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline
Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier said the company is leaning on its HIV business
GE HealthCare Technologies Sticks to Growth Story After Inflation-Driven Guidance Cut
GE HealthCare Technologies (NASDAQ:GEHC) executives said the company remains confident in its long-term growth prospects despite a